Largest biotech by market cap

CRISPR Therapeutics has the lowest figure of the 24 biotech ranked by market value, at NZ$7.1B, followed by Adaptive Biotechnologies (NZ$8.4B) and Scholar Rock Holding (NZ$10B). Figures as of 18 Nov 2026, 13:16 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
CRISPR TherapeuticsNZ$7.1B
Median
NZ$18.9B
Combined market value
NZ$1.54T
Countries
5

Market values as of .

Largest biotech by market cap
#CompanyMarket cap ↑PriceToday1 yearPrice, 30 daysCountry
1CRISPR TherapeuticsCRSP · Health CareNZ$7.1BNZ$73.01 0.54% down 21% down Switzerland
2Adaptive BiotechnologiesADPT · Health CareNZ$8.4BNZ$51.81 2.22% up 88% up United States
3Scholar Rock HoldingSRRK · Health CareNZ$10BNZ$81.97 1.21% up 14% up United States
4Kodiak SciencesKOD · Health CareNZ$11.5BNZ$176.02 3.90% down 396% up United States
5ImmunityBioIBRX · Health CareNZ$12.1BNZ$11.38 4.68% up 193% up United States
6ImmunovantIMVT · Health CareNZ$12.5BNZ$60.39 0.21% down 43% up United States
7CG OncologyCGON · Health CareNZ$12.8BNZ$143.54 6.89% down 85% up United States
8Twist BioscienceTWST · Health CareNZ$13.9BNZ$203.66 6.63% up 340% up United States
9Krystal BiotechKRYS · Health CareNZ$16.1BNZ$542.88 0.22% up 46% up United States
10VaxcytePCVX · Health CareNZ$17.1BNZ$108.01 3.59% down 22% up United States
11QiagenQGEN · Health CareNZ$18.7BNZ$90.47 0.12% down 12% up Netherlands
12RepligenRGEN · Health CareNZ$18.9BNZ$294.91 0.37% down 5% up United States
13Kymera TherapeuticsKYMR · Health CareNZ$18.9BNZ$220.97 3.44% down 87% up United States
14Halozyme TherapeuticsHALO · Health CareNZ$19.9BNZ$174.51 0.55% down 37% up United States
15Bio-TechneTECH · Health CareNZ$20.7BNZ$132.07 0.22% down 26% up United States
16ExelixisEXEL · Health CareNZ$30.4BNZ$124.56 2.09% up 63% up United States
17Neurocrine BiosciencesNBIX · Health CareNZ$30.5BNZ$301.71 0.37% up 20% up United States
18BioNTechBNTX · Health CareNZ$38.3BNZ$154.31 0.47% down 16% down Germany
19Revolution MedicinesRVMD · Health CareNZ$64BNZ$295.84 2.50% down 131% up United States
20BiogenBIIB · Health CareNZ$67.4BNZ$456.04 0.34% down 49% up United States
21argenxARGX · Health CareNZ$108.4BNZ$1,722.97 0.36% down 4% up Belgium
22ModernaMRNA · Health CareNZ$152.2BNZ$376.05 3.93% down 755% up United States
23Gilead SciencesGILD · Health CareNZ$384BNZ$309.60 1.60% up 33% up United States
24AmgenAMGN · Health CareNZ$450.4BNZ$832.70 0.95% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8184 NZD).

Questions and answers

Which biotech have the lowest market cap?

CRISPR Therapeutics (NZ$7.1B), Adaptive Biotechnologies (NZ$8.4B) and Scholar Rock Holding (NZ$10B) have the lowest market cap of the 24 biotech ranked here as of 18 Nov 2026, 13:16 UTC.

How many biotech are in this ranking?

24 are ranked by market value.

What are these biotech worth together?

The 24 biotech ranked by market value have a combined market value of NZ$1.54T as of 18 Nov 2026, 13:16 UTC.

What does ranking by market value measure?

What the stock market values the whole company at: its share price times the number of its shares.

Cite this page

Funkfolio, “Largest biotech by market cap”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech

Underlying data: Yahoo Finance; SEC EDGAR.